Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of AbCellera Biologics Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of AbCellera Biologics Inc through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Heat Biologics (NASDAQ:HTBX) Earns Sell Rating from Analysts at StockNews.com via ETF Daily News
Tesla won't set up manufacturing plant in India until allowed to first sell and service cars, Elon Musk says via Yahoo Finance
Fathom Digital Manufacturing (NYSE:FATH) Upgraded by Zacks Investment Research to Buy via ETF Daily News
Lee & Man Paper Manufacturing Limited (OTCMKTS:LMPMY) Sees Significant Increase in Short Interest via ETF Daily News
Modine Manufacturing (NYSE:MOD) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS via ETF Daily News
Cantor Fitzgerald Reaffirms “Overweight” Rating for Aziyo Biologics (NASDAQ:AZYO) via ETF Daily News
Short Interest in Art’s-Way Manufacturing Co., Inc. (NASDAQ:ARTW) Decreases By 76.7% via ETF Daily News
Financial Survey: Bone Biologics (OTC:BBLG) vs. MSA Safety (NYSE:MSA) via ETF Daily News
Eli Lilly & Co to invest $2.1 billion for two new Indiana manufacturing sites via MarketWatch
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Up 1,849.3% in May via ETF Daily News
AbCellera Biologics Inc Performance
Active Alerts for IEX:ABCL
You don't have any alerts set for IEX:ABCL.
About AbCellera Biologics Inc
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.
Real-time ABCL to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.